Menard Financial Group LLC Abbott Laboratories Transaction History

Menard Financial Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $215,061 - $259,940	-2,107 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $30,730 - $37,628	-266 Reduced 11.21%	2,107 $297,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $466 - $516	-4 Reduced 0.17%	2,373 $280,000
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $48,028 - $56,536	454 Added 23.61%	2,377 $276,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $6,421 - $7,565	59 Added 3.17%	1,923 $230,000
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $195,720 - $213,278	1,864 New	1,864 $204,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Menard Financial Group LLC with notifications on news.